Guard Therapeutics International Management
Management criteria checks 2/4
Guard Therapeutics International's CEO is Tobias Agervald, appointed in Jan 2019, has a tenure of 5.33 years. total yearly compensation is SEK5.23M, comprised of 32.8% salary and 67.2% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth SEK754.20K. The average tenure of the management team and the board of directors is 3.7 years and 4.6 years respectively.
Key information
Tobias Agervald
Chief executive officer
kr5.2m
Total compensation
CEO salary percentage | 32.8% |
CEO tenure | 5.3yrs |
CEO ownership | 0.2% |
Management average tenure | 3.7yrs |
Board average tenure | 4.6yrs |
Recent management updates
Recent updates
Companies Like Guard Therapeutics International (STO:GUARD) Could Be Quite Risky
Apr 18Guard Therapeutics International (STO:GUARD) Will Have To Spend Its Cash Wisely
Jan 04Here's Why Guard Therapeutics International (STO:GUARD) Must Use Its Cash Wisely
Sep 20Guard Therapeutics International (STO:GUARD) Is In A Good Position To Deliver On Growth Plans
Apr 06We're Keeping An Eye On Guard Therapeutics International's (STO:GUARD) Cash Burn Rate
Sep 09Here's Why We're A Bit Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Situation
Feb 19We're Not Very Worried About Guard Therapeutics International's (STO:GUARD) Cash Burn Rate
Aug 17Companies Like Guard Therapeutics International (STO:GUARD) Are In A Position To Invest In Growth
Apr 19Here's Why We're Watching Guard Therapeutics International's (STO:GUARD) Cash Burn Situation
Jan 04CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 31 2023 | n/a | n/a | -kr113m |
Sep 30 2023 | n/a | n/a | -kr137m |
Jun 30 2023 | n/a | n/a | -kr146m |
Mar 31 2023 | n/a | n/a | -kr134m |
Dec 31 2022 | kr5m | kr2m | -kr113m |
Sep 30 2022 | n/a | n/a | -kr95m |
Jun 30 2022 | n/a | n/a | -kr97m |
Mar 31 2022 | n/a | n/a | -kr88m |
Dec 31 2021 | kr4m | kr2m | -kr82m |
Sep 30 2021 | n/a | n/a | -kr69m |
Jun 30 2021 | n/a | n/a | -kr47m |
Mar 31 2021 | n/a | n/a | -kr44m |
Dec 31 2020 | kr3m | kr1m | -kr40m |
Sep 30 2020 | n/a | n/a | -kr43m |
Jun 30 2020 | n/a | n/a | -kr39m |
Mar 31 2020 | n/a | n/a | -kr41m |
Dec 31 2019 | kr4m | kr1m | -kr45m |
Compensation vs Market: Tobias's total compensation ($USD483.56K) is above average for companies of similar size in the Swedish market ($USD251.23K).
Compensation vs Earnings: Tobias's compensation has increased whilst the company is unprofitable.
CEO
Tobias Agervald (47 yo)
5.3yrs
Tenure
kr5,230,000
Compensation
Mr. Tobias Larsson Agervald has been Chief Executive Officer at Guard Therapeutics International AB (publ) (formerly known as A1M Pharma AB (publ))since January 15, 2019 and served as its Chief Medical Off...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Executive Officer | 5.3yrs | kr5.23m | 0.25% SEK 754.2k | |
Chief Financial Officer | 3.7yrs | no data | 0.028% SEK 85.3k | |
C.S.O | 4.9yrs | no data | no data | |
Head of Preclinical Science | 3.8yrs | no data | no data | |
Head of Clinical Operations | 3yrs | no data | 0.019% SEK 58.5k | |
Chief Medical Officer | 2.3yrs | no data | no data | |
Head of Chemistry | 2yrs | no data | 0.0020% SEK 6.0k |
3.7yrs
Average Tenure
50yo
Average Age
Experienced Management: GUARD's management team is considered experienced (3.7 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Director | 4.6yrs | kr136.00k | 0.0080% SEK 24.0k | |
Independent Chairman of the board | 3yrs | kr271.00k | 0.062% SEK 188.6k | |
Member of Scientific Board | no data | no data | no data | |
Independent Director | 5yrs | kr162.00k | 0.014% SEK 41.1k | |
Independent Director | 1.4yrs | kr7.00k | no data | |
Member of Scientific Board | no data | no data | no data | |
Member of Scientific Board | no data | no data | no data | |
Member of Scientific Board | no data | no data | no data | |
Member of Scientific Board | no data | no data | no data | |
Independent Director | 5yrs | kr162.00k | 0.063% SEK 190.6k | |
Member of Scientific Board | no data | no data | no data |
4.6yrs
Average Tenure
60yo
Average Age
Experienced Board: GUARD's board of directors are considered experienced (4.6 years average tenure).